Stem Cell and Gene Therapy for Cardiovascular Disease
β Scribed by Miller, Leslie William; Perin, Emerson C.; Taylor, Doris A.; Willerson, James T
- Publisher
- Academic Press
- Year
- 2016
- Tongue
- English
- Leaves
- 482
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Stem Cell and Gene Therapy for Cardiovascular Disease is a state-of-the-art reference that combines, in one place, the breadth and depth of information available on the topic.
As stem cell and gene therapies are the most cutting-edge therapies currently available for patients with heart failure, each section of the book provides information on medical trials from contributors and specialists from around the world, including not only what has been completed, but also what is planned for future research and trials.
Cardiology researchers, basic science clinicians, fellows, residents, students, and industry professionals will find this book an invaluable resource for further study on the topic.
- Provides information on stem and gene therapy medical trials from contributors and specialists around the world, including not only what has been completed, but also what is planned for future research and trials
- Presents topics that can be applied to allogeneic cells, mesenchymal cells, gene therapy, cardiomyoctyes, iPS cells, MAPC's, and organogenesis
- Covers the three areas with the greatest clinical trials to date: chronic limb ischemia, chronic angina, and acute MI
- Covers the prevailing opinions on how to harness the bodyβs natural repair mechanisms
- Ideal resource for cardiology researchers, basic science clinicians, fellows, residents, students, and industry professionals
β¦ Table of Contents
Content:
Front-matter,Copyright,List of Contributors,Preface,Regenerative Medicine and the Cardiovascular System: A Good Start*Entitled to full textPart I: Stem CellsChapter 1 - Introduction and Overview of Stem Cells, Pages 3-11, Leslie W. Miller, Emerson C. Perin
Chapter 2 - Pathological Assessment of Experimental Models of Stem Cell and Other Regenerative Therapies, Pages 13-23, Deborah Vela, L. Maximilian Buja
Chapter 3 - Large Animal Models for Cardiac Cell Therapy, Pages 25-36, Elton Migliati
Chapter 4 - Role of Paracrine Mechanisms, Pages 39-48, Conrad P. Hodgkinson, JosΓ© A. Gomez, Akshay Bareja, Victor J. Dzau
Chapter 5 - Impact of Telomere Shortening with Age in Stem Cell Therapy: New Strategies to Increase Telomere Length, Pages 49-58, Nathalie Nguyen, Nirmala Hariharan, Mark A. Sussman
Chapter 6 - Peripheral Arterial Disease, Pages 61-78, Douglas W. Losordo, Amy Chung, Zhen Chen, John P. Cooke
Chapter 7 - Cell Therapy for Refractory Angina, Pages 79-90, Sandeep K. Krishnan, E. Marc Jolicoeur, Timothy D. Henry
Chapter 8A - Stem Cell Therapy for Acute Myocardial Infarction: The European Experience, Pages 91-99, Leslie W. Miller
Chapter 8B - Acute Myocardial Infarction: The United States Experience, Pages 101-110, Jay H. Traverse
Chapter 9 - Autologous Bone Marrow Cells for Chronic Ischemic Heart Failure, Pages 111-116, Amir Gahremanpour, Emerson C. Perin
Chapter 10 - Adipose-Derived Stem Cells, Pages 119-135, W. Gathier, Z. TΓΌrktaΕ, H.J. Duckers
Chapter 11 - Mesenchymal Stem Cells, Pages 139-150, Amit N. Patel, Courtney E. Bartlett, Thomas E. Ichim
Chapter 12 - Allogeneic versus Autologous Source: Comparative Effects, Pages 151-168, Sabrina Taldone, Ivonne Hernandez Schulman, Wayne Balkan, Joshua M. Hare
Chapter 13 - Allogeneic Alternatives to Autologous Bone Marrow: The MSC Clinical Trials of Acute MI with MSCs, Pages 169-179, Angela Castellanos, Wayne Balkan, Ivonne Hernandez Schulman, Joshua M. Hare
Chapter 14 - Allogeneic Alternatives to Autologous Bone Marrow: The MSC Combined Cell Strategies, Pages 181-192, Wayne Balkan, Ivonne Hernandez Schulman, Joshua M. Hare
Chapter 15 - Clinical Trials to Date with MSCs: Heart Failure, Pages 193-197, Luis Felipe Silva Smidt, Emerson C. Perin
Chapter 16 - Therapy with c-kitPOS Cardiac Stem Cells for Ischemic Cardiomyopathy, Pages 201-215, Kyung U. Hong, Roberto Bolli
Chapter 17 - Cardiosphere-Derived Cells, Pages 217-222, Rachel Ruckdeschel Smith
Chapter 18 - Cardiovascular Regenerative Cell Therapy Using Umbilical Cord and Endometrial Cells, Pages 225-231, Amit N. Patel, Thomas E. Ichim
Chapter 19 - Cardiopoietic Stem Cells for Heart Failure Therapy, Pages 235-241, Atta Behfar, Andre Terzic
Chapter 20 - Transformation to Inducible Pluripotent Stem Cells, Pages 243-265, Kazuki Kodo, Sang-Ging Ong, Joseph C. Wu
Chapter 21 - Multipotent Adult Progenitor Cells (MAPCs) for Cardiovascular and Neurologic Diseases, Pages 267-275, Valerie D. Roobrouck, Philip R. Roelandt, Catherine M. Verfaillie
Chapter 22 - Intravenous, Intracoronary, Transendocardial, and Advential Delivery, Pages 279-287, Emerson C. Perin
Chapter 23 - Retrograde Coronary Sinus Delivery for Cardiac Cell Therapy, Pages 289-293, Amit N. Patel
Chapter 24 - Current Perspectives on Methods for Administering Human Pluripotent Stem Cell-Derived Cells for Myocardial Repair, Pages 297-308, Jun Fujita, Keiichi Fukuda, Leslie W. Miller, Jianyi (Jay) Zhang
Chapter 25 - Acellular Injectable Biomaterials for Treating Cardiovascular Disease, Pages 309-325, Roberto Gaetani, Jessica Ungerleider, Karen L. Christman
Chapter 26 - Scaffold-Based Cell Delivery for Cardiac Repair, Pages 327-339, Lisle Blackbourn, Eric G. Schmuck, Amish N. Raval
Chapter 27 - Biomaterial: Alginate, Pages 341-348, David S. Lee, Randall J. Lee
Chapter 28 - Organogenesis, Pages 349-373, Andrea S. Gobin, Doris A. Taylor, Eric Chau, Luiz C. Sampaio
Chapter 29 - Gene Therapy for Cardiovascular Diseases, Pages 377-387, Thomas Weber, Lior Zangi, Roger J. Hajjar
Chapter 30 - SERCA2a Gene Therapy for Heart Failure, Pages 389-400, Antoine H. Chaanine, Alex Yaroshinsky, Roger J. Hajjar
Chapter 31 - SDF-1 for Cardiac Repair, Pages 401-407, Deephak Swaminath, Brittany M. Penn, Marc S. Penn
Chapter 32 - Gene Therapy in Critical Limb Ischemia, Pages 409-416, Robert M. Cole, Alan T. Hirsch, Timothy D. Henry
Chapter 33 - Use of Gene Modified Stem Cells for Acute Myocardial Infarction, Pages 417-432, Michael J.B. Kutryk, Duncan J. Stewart
Chapter 34 - The History and Future of the Cardiovascular Cell Therapy Research Network, Pages 435-443, Robert D. Simari, Ray F. Ebert, Lem MoyΓ©
Chapter 35 - Signature of RespondersβLessons from Clinical Samples, Pages 445-460, Micheline Resende, Luiz C. Sampaio, Aaron Orozco, Doris A. Taylor
Chapter 36 - Adjunctive Therapies with LVADs: Combining Biological and Mechanical Regenerative Therapies, Pages 461-469, Deborah D. Ascheim, William Hiesinger, Annetine C. Gelijns, Y. Joseph Woo, Kimberly N. Hong
Chapter 37 - Trials in Non-ischemic Heart Failure, Pages 471-483, Bojan Vrtovec
Chapter 38 - New Strategies to Enhance Stem Cell Homing for Tissue Repair, Pages 485-496, Leslie W. Miller
Chapter 39 - Cell Therapy in Ischemic Stroke, Pages 497-507, Vivek Misra, Sean I. Savitz
Index, Pages 509-515
π SIMILAR VOLUMES
This book is the definitive reference on two of the most exciting areas of cardiovascular research β myocardial regeneration and stem cell therapy β for the treatment of disease. Edited by pioneers in the area, with contributions from every major investigator worldwide, it covers: <p> <ul> <li>The b
<p>Stem cell transplantation may be complicated by treatment-related mortality and like the immune system that it regenerates has equal potential to either create and preserve or destroy. The dual nature that defines stem cells is differentiation that ultimately leads to death and self-renewal, whic
<p>Provides detailed discussions of the most recent developments in gene mapping and manipulation to improve the diagnosis, detection, prevention, and treatment of various cardiovascular diseases--including hypertension, arrhythmias, inherited cariomyopathies, hyperlipidemia, aortic aneurysms, Marfa
<p><p>This book presents state-of-the-art pre-clinical models and clinical applications of stem-cell-based therapies applied to different lung diseases, with a special focus on the translation of bench data into clinical studies. </p><p>Starting with the assumption that abnormal lung tissue repair a